Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Natural Killer Cells and Thyroid Diseases.
Lee EK, Sunwoo JB. Lee EK, et al. Endocrinol Metab (Seoul). 2019 Jun;34(2):132-137. doi: 10.3803/EnM.2019.34.2.132. Endocrinol Metab (Seoul). 2019. PMID: 31257741 Free PMC article. Review.
Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
Moon JH, Kim JH, Lee EK, Lee KE, Kong SH, Kim YK, Jung WJ, Lee CY, Yoo RE, Hwangbo Y, Song YS, Kim MJ, Cho SW, Kim SJ, Jung EJ, Choi JY, Ryu CH, Lee YJ, Hah JH, Jung YS, Ryu J, Hwang Y, Park SK, Sung HK, Yi KH, Park DJ, Park YJ. Moon JH, et al. Among authors: lee ek, lee cy, lee ke, lee yj. Endocrinol Metab (Seoul). 2018 Jun;33(2):278-286. doi: 10.3803/EnM.2018.33.2.278. Endocrinol Metab (Seoul). 2018. PMID: 29947183 Free PMC article.
A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol.
Lee EK, Lee YJ, Park YJ, Moon JH, Yi KH, Kim KS, Lee JH, Cho SW, Joo J, Hwangbo Y, Go S, Park DJ. Lee EK, et al. Among authors: lee jh, lee yj. Endocrinol Metab (Seoul). 2020 Sep;35(3):571-577. doi: 10.3803/EnM.2020.681. Epub 2020 Sep 22. Endocrinol Metab (Seoul). 2020. PMID: 32981299 Free PMC article.
Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma.
Moon JH, Ryu CH, Cho SW, Choi JY, Chung EJ, Hah JH, Hwangbo Y, Jeong WJ, Jung YS, Kim JH, Kim MJ, Kim SJ, Kim YK, Lee CY, Lee EK, Lee JY, Lee KE, Lee YJ, Lee Y, Yu HW, Park DJ, Ryu J, Park YJ. Moon JH, et al. Among authors: lee cy, lee ek, lee y, lee ke, lee jy, lee yj. J Clin Endocrinol Metab. 2021 Mar 8;106(3):724-735. doi: 10.1210/clinem/dgaa889. J Clin Endocrinol Metab. 2021. PMID: 33248442
Best Achievements in Clinical Thyroidology in 2020.
Lee EK, Park YJ. Lee EK, et al. Endocrinol Metab (Seoul). 2021 Feb;36(1):30-35. doi: 10.3803/EnM.2021.103. Epub 2021 Feb 24. Endocrinol Metab (Seoul). 2021. PMID: 33677923 Free PMC article. Review.
A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol.
Lee EK, Kang YE, Park YJ, Koo BS, Chung KW, Ku EJ, Won HR, Yoo WS, Jeon E, Paek SH, Lee YS, Lim DM, Suh YJ, Park HK, Kim HJ, Kim BH, Kim M, Kim SW, Yi KH, Park SK, Jung EJ, Choi JY, Bae JS, Hong JH, Nam KH, Lee YK, Yu HW, Go S, Kang YM; MASTER study group. Lee EK, et al. Among authors: lee ys, lee yk. Endocrinol Metab (Seoul). 2021 Jun;36(3):574-581. doi: 10.3803/EnM.2020.943. Epub 2021 May 26. Endocrinol Metab (Seoul). 2021. PMID: 34034365 Free PMC article.
1,373 results